| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |